After his seven-year-old nephew developed brain lesions, Salynt founder Jeremy Lawson redirected his AI company toward neuroimaging. Now the Baltimore startup is working toward its first independent clinical validation study and raising $100,000 to help fund the next stage. A phone call from his mother changed the direction of Jeremy Lawson’s company. Lawson’s seven-year-old nephew was experiencing brain lesions, and his family in Mississippi had spent months trying to understand what was happening. His mother called him in Baltimore with a simple request: “Jeremy, you need to do something.” “I’m just a mathematician. What can I do?” Lawson remembers thinking.

The postA Family Crisis Led Salynt’s Founder to Build AI for Brain Tumor Imagingappeared first onSHOPPE BLACK.